Cargando…
Failure to Treat Life-Threatening Ventricular Tachyarrhythmias in Contemporary Implantable Cardioverter–Defibrillators: Implications for Strategic Programming
BACKGROUND: In clinical trials, manufacturer-specific, strategic programming of implantable cardioverter–defibrillators (ICDs), including faster detection rates, reduces unnecessary therapy but permits therapy for ventricular tachycardia/ventricular fibrillation (VF). Present consensus recommends a...
Autores principales: | Thøgersen, Anna Margrethe, Larsen, Jacob Moesgaard, Johansen, Jens Brock, Abedin, Moeen, Swerdlow, Charles D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5610568/ https://www.ncbi.nlm.nih.gov/pubmed/28916511 http://dx.doi.org/10.1161/CIRCEP.117.005305 |
Ejemplares similares
-
Association of Air Pollution with Increased Incidence of Ventricular Tachyarrhythmias Recorded by Implanted Cardioverter Defibrillators
por: Dockery, Douglas W., et al.
Publicado: (2005) -
Left ventricle remodeling predicts the recurrence of ventricular tachyarrhythmias in implantable cardioverter defibrillator recipients for secondary prevention
por: Lee, Wei-Chieh, et al.
Publicado: (2016) -
Association of Night-Time Heart Rate With Ventricular Tachyarrhythmias, Appropriate and Inappropriate Implantable Cardioverter-Defibrillator Shocks
por: Sun, Xuerong, et al.
Publicado: (2021) -
T-Wave Oversensing with Contemporary Implantable Cardioverter–Defibrillators
por: Strik, Marc, et al.
Publicado: (2023) -
Sex Differences in the Risk of First and Recurrent Ventricular Tachyarrhythmias Among Patients Receiving an Implantable Cardioverter-Defibrillator for Primary Prevention
por: Saxena, Shireen, et al.
Publicado: (2022)